Optomed Q3 (Review) - Solid growth with a positive devices segment development
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Redeye via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
2025-11-07 08:48:00
Redeye provides an update following Optomed’s Q3 2025 report. The report was solid in our view, with a strong development in the devices segment, and the outlook remains positive. Changes have been made to our sales and OPEX forecasts in this update; however, the fair value range remains intact.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/